A 37-year-old man who presented with one year history of lower back and right buttock pain was investigated with contrast enhanced computed tomography (CT), magnetic resonance imaging (MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography which revealed a diagnosis of primary fibroblastic osteosarcoma of the lumbar vertebra. This case highlights the importance of PET/CT imaging. A 37-year-old man presented with one year history of lower back and right buttock pain. He was investigated with contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Enhanced CT and MRI images show an T1 iso-to-slight high-signal intensity mass with irregular osteolytic lesion in the vertebral body, both pedicle, transverse, and spinous process of L4 with bony cortical expansion and destruction. Moreover, 18F-FDG PET/CT demonstrated an area of increased 18F-FDG uptake with a maximum standardized value (SUVmax) of 3.2, corresponding to an osteolytic lesion occupying the right vertebral body, both pedicle, transverse, and spinous process of L4 spine suspicious for malignant bone tumor [ Figure 1 ]. No other areas of abnormal 18F-FDG uptake were detected in the rest of the body. Based on this PET/CT finding, the patient had a biopsy of the L4 lesion. Histology demonstrated the presence of a fibroblastic osteosarcoma (OS), and the patient was addressed to surgical resection.
A 37-year-old man presented with one year history of lower back and right buttock pain. He was investigated with contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Enhanced CT and MRI images show an T1 iso-to-slight high-signal intensity mass with irregular osteolytic lesion in the vertebral body, both pedicle, transverse, and spinous process of L4 with bony cortical expansion and destruction. Moreover, 18F-FDG PET/CT demonstrated an area of increased 18F-FDG uptake with a maximum standardized value (SUVmax) of 3.2, corresponding to an osteolytic lesion occupying the right vertebral body, both pedicle, transverse, and spinous process of L4 spine suspicious for malignant bone tumor [ Figure 1 ]. No other areas of abnormal 18F-FDG uptake were detected in the rest of the body. Based on this PET/CT finding, the patient had a biopsy of the L4 lesion. Histology demonstrated the presence of a fibroblastic osteosarcoma (OS), and the patient was addressed to surgical resection.
OS is a highly malignant sarcoma with the production of osteoid matrix. The most common sites of origin are the metaphyseal regions of the distal femur, proximal tibia, and proximal humerus. [1] Vertebral involvement is very rare with 2%-4% of all cases and fibroblastic subtype is a low rate with 25% of all conventional OS. [2] It tends to occur in a slightly older age group, with a mean age of 38 years, than OS of the extremity. [3] The role of 18F-FDG PET/CT in patients with appendicular OS is well known for initial staging, detecting recurrence, and/or response monitoring, whereas only a little articles evaluated the usefulness of primary vertebral OS. [4, 5] The present case 18F-FDG PET/CT was useful in evaluating a malignant potential of the spine mimicking bone metastasis or benign bone tumor in a patient with back pain. Although rare, primary fibroblastic OS should be considered one of the differential diagnoses of vertebral lesions detected by 18F-FDG PET/CT.
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